• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Canada·Healthcare·NVG.CN
Share

Nass Valley Gateway Ltd. Stocks

CA$ 0Last Updated 23.03.2026

Issuer Rating

1/7
Performance

Poor

Risk

High

Recommendation

Sell

Market Cap

CA$ 8.38M

CA$ 0
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Nass Valley Gateway Ltd. sells and distributes hemp based cannabidiol (CBD) with zero tetrahydrocannabinol content products for pet and human consumption in the United States and internationally. It sells CBD infused skin, bath, and body care products under the Nass Valley Gardens brand through retail, wholesale, direct sales, and digital sales channels. The company is based in Vancouver, Canada.

Company Valuation

Greatly overvalued
1/7

Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

05.08.2026 15:00

Attovia IPO: Shares in the biotech company, backed by Goldman Sachs, are now available

05.08.2026 14:43

Axios has learned details about the deal between the U.S. and Iran: it calls for keeping the Strait of Hormuz open for 60 days

05.08.2026 13:24

AMD shares plummeted 9% following Musk's decision to source only Nvidia chips for SpaceX

05.08.2026 12:31

"A Startup by Necessity": Compass Could Be the First to Bring a Psychedelic to the U.S. What About Its Stock?

05.08.2026 11:43

Following Musk's Example: Revolut's CEO Could Receive Europe's Largest Bonus Package

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026